SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-19-003417
Filing Date
2019-08-15
Accepted
2019-08-15 13:28:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 NOVABAY PHARMACEUTICALS, INC. p19-1748sc13g.htm SC 13G 100243
  Complete submission text file 0000902664-19-003417.txt   101726
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83670 | Film No.: 191029549
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G